Trial Profile
Clinical Trials Insight: 700048731
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2009
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Ribavirin (Primary)
- Indications Hepatic fibrosis; Hepatitis C
- Focus Therapeutic Use
- 29 Oct 2009 Interim results presented at the 60th Annual Meeting of the American Association for the Study of Liver Diseases.
- 02 Sep 2009 New trial record
- 02 Sep 2009 Interim results have been reported at 14th Congress of the European Society for Organ Transplantation